ALLMedicine™ Cerebral Venous Thrombosis Center

Feb 17th, 2021 - Current guidelines do not recommend direct oral anticoagulants (DOACs) to treat cerebral venous thrombosis (CVT) despite their benefits over standard therapy. We performed a systematic review to summarise the published experience of DOAC therapy i...

Feb 16th, 2021 - New Oral Anticoagulants (NOACs) such as Rivaroxaban are introduced as alternatives to conventional vitamin-K antagonists in the long-term treatment of thrombotic events due to their lower bleeding risk. There is a lack of evidence on the effective...

Feb 6th, 2021 - Cerebral venous thrombosis (CVT) has various clinical presentations and has a median onset delay of 7 days. So it is important to find more identifiable early imaging manifestations for CVT. This was a retrospective study. Patients with CVT (CVT g...

Feb 3rd, 2021 - Cerebrovascular accidents (CVAs) after percutaneous coronary intervention (PCI), although rare, are associated with high in-hospital morbidity and mortality rates. Cerebral venous thrombosis (CVT) is an uncommon cause of CVAs compared with arteria...

Jan 11th, 2021 - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection predisposes patients to arterial and venous thrombosis. This study aimed to systematically review the available evidence in the literature for cerebral venous thrombosis (CVT) ...

Aug 23rd, 2017 - Current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological Societies in 2010. We aimed to update the previous European Federation of Neurological Societies guidelines usin...

Jul 27th, 2011 - New guidelines for the management of cerebral venous thrombosis.|2011|Aoun SG,Rahme RJ,Batjer HH,Bendok BR,|therapeutic use,diagnosis,therapy,diagnosis,therapy,

Feb 4th, 2011 - The purpose of this statement is to provide an overview of cerebral venous sinus thrombosis and to provide recommendations for its diagnosis, management, and treatment. The intended audience is physicians and other healthcare providers who are res...

Feb 17th, 2021 - Current guidelines do not recommend direct oral anticoagulants (DOACs) to treat cerebral venous thrombosis (CVT) despite their benefits over standard therapy. We performed a systematic review to summarise the published experience of DOAC therapy i...

Feb 16th, 2021 - New Oral Anticoagulants (NOACs) such as Rivaroxaban are introduced as alternatives to conventional vitamin-K antagonists in the long-term treatment of thrombotic events due to their lower bleeding risk. There is a lack of evidence on the effective...

Feb 6th, 2021 - Cerebral venous thrombosis (CVT) has various clinical presentations and has a median onset delay of 7 days. So it is important to find more identifiable early imaging manifestations for CVT. This was a retrospective study. Patients with CVT (CVT g...

Feb 3rd, 2021 - Cerebrovascular accidents (CVAs) after percutaneous coronary intervention (PCI), although rare, are associated with high in-hospital morbidity and mortality rates. Cerebral venous thrombosis (CVT) is an uncommon cause of CVAs compared with arteria...

Jan 11th, 2021 - Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection predisposes patients to arterial and venous thrombosis. This study aimed to systematically review the available evidence in the literature for cerebral venous thrombosis (CVT) ...

Sep 3rd, 2020 - The US incidence of cerebral venous thrombosis (CVT), an uncommon but important cause of stroke, is more than three times greater than previously reported, new research suggests. However, whether this is a real increase or simply an artifact of be...

Sep 3rd, 2020 - The US incidence of cerebral venous thrombosis (CVT), an uncommon but important cause of stroke, is more than three times greater than previously reported, new research suggests. However, whether this is a real increase or simply an artifact of be...

Sep 14th, 2017 - New guidelines for the diagnosis and treatment of cerebral venous thrombosis (CVT) have been issued by the European Stroke Organisation. The guidelines, published in the European Journal of Neurology, have also been endorsed by the European Academ...

Sep 14th, 2017 - New guidelines for the diagnosis and treatment of cerebral venous thrombosis (CVT) have been issued by the European Stroke Organisation. The guidelines, published in the European Journal of Neurology, have also been endorsed by the European Academ...

Jul 14th, 2017 - Given the variable and often nonspecific clinical presentations of these cases, unenhanced CT typically is the first imaging study ordered. According to the literature, noncontrast CT is not sensitive (25%-56%) in detecting CVT, and findings are n.